Concepedia

Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UK

C Poole, M. Lebmeier, Roberta Ara, Rachid Rafia, C. J. Currie

Lara D. Veeken · 2010 · 45 citations · 21 references

DOI

Abstract

Treatment of people with PsA resulted in considerable financial costs and these costs varied markedly by disease severity.

References

21

Measurement of patient outcome in arthritis

James F. Fries, Patricia W. Spitz, R. Guy Kraines et al. · Arthritis & Rheumatism · 1980 · 4.3K citations

, , +13

Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression

Philip J. Mease, Alan Kivitz, Francis X. Burch et al. · Arthritis & Rheumatism · 2004 · 882 citations

Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Chenglong Han, Don Robinson, Monica Hackett et al. · PubMed · 2006 · 720 citations

A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction

Kim Papp, Stephen K. Tyring, M. Lahfa et al. · British Journal of Dermatology · 2005 · 687 citations

Psoriatic Arthritis (PSA) - An Analysis of 220 Patients

Dafna D. Gladman, Rhonda Shuckett, Michelle Russell et al. · QJM · 1987 · 637 citations

, , +14